BRAINSTORM CELL THERAPEUTICS INC. Form 10-K/A: Amended annual report
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2019-04-01: Form 10-K/A; Period of report 2018-12-31; Description FORM 10-K/A; Document tv517784_10ka.htm.
- 2011-12-28: Form 10-K/A; Period of report 2010-12-31; Description FORM 10-K/A; Document v239327_10ka.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2019-04-01 | 10-K/A | 2018-12-31 | FORM 10-K/A | tv517784_10ka.htm |
| 2011-12-28 | 10-K/A | 2010-12-31 | FORM 10-K/A | v239327_10ka.htm |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| Pluri Inc. (PLUR) | $0.014B | ||
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |